Chr. Hansen Holding acquired by Novozymes
Novozymes acquired Chr. Hansen Holding, a Denmark wellness brand, on Jan 29, 2024.
Preliminary: The announcement date, completion date, deal status, EV/revenue, EV/EBITDA, metric basis and value notes are not yet independently verified. Sources conflict on the value basis. The EV/EBITDA is outside the usual range for comps, so treat it with caution.
Transaction summary
Value and multiples
100% enterprise value
USD 12B
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
9.3x
Unverified
Period not stated
Basis: FundComb estimate
EV / EBITDA
26.2x
Unverified
EBITDA basis not stated
Basis: FundComb estimate
Basis
- No underlying revenue, EBITDA, or enterprise value basis was provided; multiples were preserved from the user-supplied spreadsheet without recalculation.
Source summary
Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner - GlobeNewswire
ConfirmedContinue your research
Related transaction comps
BIO-CAT Enzymes & Microbials acquired by Lallemand Inc.
2026-07-31 · Confirmed
View transaction → FoodGaneden acquired by Kerry Group
2017-10-11 · Confirmed
View transaction → FoodBioCare Copenhagen acquired by DSM
2017-12-22 · Confirmed
View transaction → FoodDuPont Nutrition & Biosciences acquired by International Flavors & Fragrances (IFF)
2005-07-01 · Estimated
View transaction →